FDA cleared UVB Solius offers the only FDA-cleared over-the-counter UVB light therapy device, presenting a strong value proposition for direct-to-consumer wellness channels and professional clinics seeking regulated, safe home-use solutions.

Personalized dosing The device analyzes the user's skin to deliver an optimal UVB dose with significantly reduced UV risk, enabling sales opportunities around dermatology clinics, spa/wellness centers, and telemedicine partnerships that emphasize personalized light therapy.

Recent funding Recent Series A funding of 23 million dollars and the launch of Solius Pro create momentum for scaled distribution, enabling partnerships with retailers, professional distributors, and clinic networks seeking to offer innovative light therapy devices.

Home and pro market Solius targets both home and professional wellness settings, opening cross-sell opportunities with fitness studios, dermatology practices, aesthetic clinics, and corporate wellness programs looking for at-home therapies aligned with clinician oversight.

Strategic leadership Strong leadership with experience in medical devices and prior ventilator market success signals credibility for channel partners, potential co-marketing with healthcare providers, and engagement with investors and industry partners to expand reach.